Close Menu

NEW YORK — Henry Schein said on Wednesday that it has signed on as the exclusive US distributor of a point-of-care SARS-CoV-2 test kit commercialized by Becton Dickinson and BioMedomics.

The test, developed and manufactured by BioMedomics, is designed to detect immunoglobulin M and immunoglobulin G antibodies associated with SARS-CoV-2 infection in blood, serum, or plasma. Results are available within 15 minutes.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 


As new variants of SARS-CoV-2 circulate around the globe, there is growing concern among clinical laboratories that these variants may impact their ability to accurately detect the virus.